0001225208-19-003777.txt : 20190226 0001225208-19-003777.hdr.sgml : 20190226 20190226194537 ACCESSION NUMBER: 0001225208-19-003777 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190223 FILED AS OF DATE: 20190226 DATE AS OF CHANGE: 20190226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANKLER DOUGLAS M CENTRAL INDEX KEY: 0001488270 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 19635313 MAIL ADDRESS: STREET 1: PFIZER INC. ATTN: CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2019-02-23 0000078003 PFIZER INC PFE 0001488270 LANKLER DOUGLAS M PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Executive Vice President Common Stock 2019-02-23 4 M 0 43724.0000 21.0300 A 83781.0000 D Common Stock 2019-02-23 4 F 0 11343.0000 42.9600 D 72438.0000 D Common Stock 2019-02-23 4 F 0 13615.0000 41.9100 D 58823.0000 D Common Stock 1503.0000 I By Rule 16b-3 Plan Stock Appreciation Rights 21.0300 2019-02-23 4 M 0 43724.0000 0.0000 D 2019-02-23 2019-02-23 Common Stock 43724.0000 0.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Price is the closing price of Pfizer common stock on February 22, 2019 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Susan E. Grant, by power of atty., for Douglas M. Lankler 2019-02-26